MIT scientists use a new type of nanoparticle to make vaccines more powerful
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
Thirteen postdocs join program that emphasizes community and prioritizes professional development.
Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
Award honors “scientists who have made a transformational contribution toward the improvement of human health.”
Two professors and three additional alumni recognized for “dreaming up solutions to global challenges — advancing health, sustainability, and human connection.”
The MIT professor emerita and pioneering molecular biologist is being honored for her advocacy for women in science.
Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
MIT Koch Institute researchers Daniel Anderson and Ana Jaklenec, plus 11 MIT alumni, are honored for inventions that have made a tangible impact on society.
Cancer nanomedicine was on display at the 2023 White House Demo Day.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.